The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-α

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 11, 2002, Pages 1859-1864

  Adams, Michael R ^a   Golden, Deborah L ^a   Register, Thomas C ^a   Anthony, Mary S ^a   Hodgin, Jeffrey B ^a   Maeda, Nobuyo ^a   Williams, J Koudy ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Atherosclerosis; Estrogen receptors; Mice; Phytoestrogens; Soy

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; HIGH DENSITY LIPOPROTEIN; ISOFLAVONE; LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART PROTECTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN DIET; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL ESTERS; CROSSES, GENETIC; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; ISOFLAVONES; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OVARIECTOMY; RECEPTORS, ESTROGEN; SOYBEAN PROTEINS;

EID: 0036847363     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000042202.42136.D0     Document Type: Article

References (54)

1. Kritchevsky D. Dietary protein and atherosclerosis: A review of the early history. J Nutr. 1995;125:589S-593S.
2. Lovati MR, Manzoni C, Corsini A, Granata A, Frattini R, Rumagalli R, Sirtori CR. Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr. 1992;122:1971-1978.
3. Lovati MT, Manzoni D, Corsini A, Granata A, Fumagalli R, Sirtori CR. 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. J Nutr. 1996;126:2831-2842.
4. Sirtori CR, Even R, Lovati MR. Soybean protein diet and plasma cholesterol: From therapy to molecular mechanisms. Ann NY Acad Sci. 1993;676:188-201.
5. Sugano M, Goto S, Yamada Y, Yoshida K, Hashimoto Y, Matsuo T, Kimoto M. Cholesterol-lowering activity of soybean protein in rats. J Nutr. 1990;120:977-985.
6. Sugano M, Koba K. Dietary protein and lipid metabolism: A mulfifunctional effect. Ann NY Acad Sci. 1993;676:215-221.
7. Wang M-F, Yamamoto S, Chung H-M, Chung S-Y, Miyatini S, Mori M, Okita T, Sugano M. Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J Nutr Sci Vitaminol. 1995;41:187-195.
8. Anthony MS. Soy and cardiovascular disease: Cholesterol lowering and beyond. J Nutr. 2000;130:662S-663S.
9. Ni W, Tsuda Y, Sakono M, Imaizumi K. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr. 1998;128:1884-1889.
10. Yamakoshi J, Piskula MK, Izumi T, Tobe K, Saito M, Kataoka S, Obata A, Kikuchi M. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr. 2000;130:1887-1893.
11. Adams MR, Golden DL, Anthony MS, Register TC, Williams JK. The inhibitory effect of soy protein isolate in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins. J Nutr. 2002;132:43-49.
12. Hodgson JM, Croft KD, Puddey IB, Mori TA, Bellin LJ. Soybean isoflavones and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem. 1996;7:664-669.
13. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A. 1998;95:3106-3110.
14. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 1997;46:698-705.
15. Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TAB. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am J Clin Nutr. 2000;72:395-400.
16. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863-870.
17. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-4263.
18. Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson J-A, Hayry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A. 1999;96:7077-7082.
19. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci U S A. 199;96:15133-15136.
20. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson J-A, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002;295:505-508.
21. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor α is a major mediator of 17β-estradiol's atheroprotective effect on lesion size in Apoe-/- mice. J Clin Invest. 2001;107:333-340.
22. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
23. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993;90:11162-11166.
24. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson J-A, Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci U S A. 1998;95:15677-15682.
25. Carroll RM, Rudel LL. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gelfiltration chromatography. J Lipid Res. 1983;24:200-207.
26. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
27. Rudel LL, Kelly K, Sawyer JK, Shah R, Wilson MD. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol. 1998;18:1818-1827.
28. Lowry OJ, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;191:265-275.
29. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol. 1997;17:2524-2531.
30. Setchell KDR, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heub JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy product supplements. J Nutr. 2001;131:1362S-1375S.
31. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull. 2001;24:351-356.
32. Shutt DA, Cox RI. Steroid and phyto-estrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972;52:299-310.
33. Sathyamoorthy N, Wang TT. Differential effects of dietary daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer. 1997;33:2384-2389.
34. Breinholt V, Hossaini A, Svendsen GW, Brouwer C, Nielsen E. Estrogenic activity of flavonoids in mice: The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol. 2000;38:555-564.
35. Nagel SC, vom Saal FS, Welshoms WV. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity. Exp Biol Med. 1998;217:300-309.
36. Watanabe S, Yamaguchi M, Sobue T, Yakahashi T, Miura T, Arai Y, Mazur W, Wahala K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998;128:1710-1715.
37. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med. 1995;208:40-43.
38. Brown NM, Setchell KD. Animal models impacted by phytoestrogens in commercial chow: Implications for pathways influenced by hormones. Lab Invest. 2001;81:735-747.
39. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17 β-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Rad Res Commun. 1990;8:167-173.
40. Negre-Salvayre A, Pieraggi M-T, Mabile L, Salvayre R. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 1993;99:207-217.
41. Wagner JD, Adams MR, Schwenke DC, Clarkson TB. Oral contraceptive treatment decreases arterial LDL degradation in female cynomolgus monkeys. Arterioscler Throm. 1992;12:716-723.
42. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively C, Adams MR. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
43. Pervin S, Singh R, Rosenfeld ME, Navab M, Chaudhuri G, Nathan L. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1575-1582.
44. Frazier-Jessen MR, Kovacs EJ. Estrogen modulation of JE/monocyte chemoattractant protein-1 in murine macrophages. J Immunol. 1995;154:1838-1845.
45. Nakai K, Itoh C, Hotta K, Itoh T, Yoshizumi M, Hiramori K. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 in human umbilical vein endothelial cells. Life Sci. 1994;54:221-227.
46. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen is mediated by NF-κB and C/EBP-β. Mol Cell Biol. 1995;15:4971-4979.
47. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagos SC. 17 β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992;89:883-891.
48. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 1996;98:36-42.
49. Azia KE, Wakefield E. Modulation of endothelial cell expression of ICAM-1, E-selectin and VCAM-1 by beta-estradiol, progesterone and dexamethasone. Cell Immunol. 1996;167:79-85.
50. Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK, DeCaterina R. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 2000;87:19-25.
51. Hamish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology. 2000;141:3403-3411.
52. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ Res. 2000;87:1006-1011.
53. Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC. Reciprocal antagonism between estrogen receptor and NF-KB in vivo. Circ Res. 2001;89:823-830.
54. Richmond R. Functional Estrogen Receptors in Articular Cartilage: Estrogen Effects on Chondrocytes and Characterization of Estrogen Receptors in Human Monocyte-Derived Macrophages [PhD Dissertation]. Winston-Salem, NC: Wake Forest University School of Medicine, 2002.